Chemical Formula: C10H19N3O5

Chemical Formula C10H19N3O5

Found 45 metabolite its formula value is C10H19N3O5

Lysylaspartic acid

(2S)-2-[(2S)-2,6-diaminohexanamido]butanedioic acid

C10H19N3O5 (261.1325)


Lysylaspartic acid is a dipeptide composed of lysine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Aspartyllysine

(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanoic acid

C10H19N3O5 (261.1325)


Aspartyllysine is a hydrophilic dipeptide composed of aspartic acid and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Aspartyllysine is widely distributed in nature and is present in wheat, fish, and other nutrients. It has been demonstrated to be absorbed by the intestinal H+/peptide transporter PepT1. It is excreted by the kidney-specific high-affinity H+/peptide cotransport system (PMID:1982012, 9922316, 7589991). alpha-Aspartyl-lysine is an hydrophilic dipeptide widely distributed in nature. It is present in wheat, fish and other nutrients. It has been demonstrated to be absorbed aided by the intestinal H+/Peptide transporter PepT1. It is excreted by the kidney-specific high-affinity H+/peptide cotransport system. (PMID: 1982012, 9922316, 7589991) [HMDB]

   

Gamma glutamyl ornithine

(4S)-4-Amino-4-{[(1S)-4-amino-1-carboxybutyl]-C-hydroxycarbonimidoyl}butanoate

C10H19N3O5 (261.1325)


Gamma glutamyl ornithine is found in human urine. - PubMed reference: 1148212. Gamma-glutamylornithine has been identified in urine from patients with the HHH syndrome (hyperornithinemia, hyperammonemia and homocitrullinuria) and with gyrate atrophy associated with hyperornithinemia. The amount of gamma-glutamylornithine excreted was 10-15 times higher than that excreted in normal subjects. - PubMed reference: 6547887.

   

N6-beta-Aspartyllysine

(2S)-2-Amino-6-{[(3S)-3-amino-3-carboxy-1-hydroxypropylidene]amino}hexanoate

C10H19N3O5 (261.1325)


N6-beta-Aspartyllysine is an unusual urinary dipeptide. This compound was observed in children in various disease states, but without any correlation with a particular symptom (PMID 618685). It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Aspartyl-Lysine

6-Amino-2-[(2-amino-3-carboxy-1-hydroxypropylidene)amino]hexanoate

C10H19N3O5 (261.1325)


Aspartyl-Lysine is a dipeptide composed of aspartate and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

gamma-Glu-Orn|gamma-Glutamyl-alpha-ornitine|L-L-N2-gamma-Glutamylornithine

gamma-Glu-Orn|gamma-Glutamyl-alpha-ornitine|L-L-N2-gamma-Glutamylornithine

C10H19N3O5 (261.1325)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

alpha-Asp-lys

N2-L-alpha-Aspartyl-L-lysine

C10H19N3O5 (261.1325)


   

&gamma

glutamyl ornithine

C10H19N3O5 (261.1325)


   

Asp-lys

2-(2,6-diaminohexanamido)butanedioic acid

C10H19N3O5 (261.1325)


A dipeptide formed from L-alpha-aspartyl and L-lysine residues.

   

Lys-asp

6-amino-2-(2-amino-3-carboxypropanamido)hexanoic acid

C10H19N3O5 (261.1325)


A dipeptide formed from L-lysine and L-aspartic acid residues.

   
   

L-Valylglycyl-L-serine

L-Valylglycyl-L-serine

C10H19N3O5 (261.1325)


   

2-(2,6-Diaminohexanoylamino)butanedioic acid

2-(2,6-Diaminohexanoylamino)butanedioic acid

C10H19N3O5 (261.1325)


   

Meso-diaminopimeloyl-alanine

Meso-diaminopimeloyl-alanine

C10H19N3O5 (261.1325)


   

2,6-Diamino-7-(1-carboxyethylamino)-7-oxoheptanoic acid

2,6-Diamino-7-(1-carboxyethylamino)-7-oxoheptanoic acid

C10H19N3O5 (261.1325)


   

Thr-Ala-Ala

Thr-Ala-Ala

C10H19N3O5 (261.1325)


A tripeptide composed of L-threonine and two L-alanine units joined by peptide linkages.

   

Alanyl-alanyl-threonine

Alanyl-alanyl-threonine

C10H19N3O5 (261.1325)


   
   
   
   

L-lysyl-D-aspartic acid

L-lysyl-D-aspartic acid

C10H19N3O5 (261.1325)


   

L-ornithyl-D-glutamic acid

L-ornithyl-D-glutamic acid

C10H19N3O5 (261.1325)


   
   
   
   

gamma-Glutamylornithine

gamma-Glutamylornithine

C10H19N3O5 (261.1325)


   

beta-Aspartyl-epsilon-lysine

beta-Aspartyl-epsilon-lysine

C10H19N3O5 (261.1325)


   
   
   

2-amino-4-[(4-amino-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(4-amino-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

C10H19N3O5 (261.1325)


   

(2s)-2-amino-4-{[(1s)-4-amino-1-carboxybutyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1s)-4-amino-1-carboxybutyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H19N3O5 (261.1325)